MTNB — MATINAS BIOPHARMA HLDGS INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 25 SEC-registered investment managers reported holding MTNB (MATINAS BIOPHARMA HLDGS INC) in their latest 13F filings, with a combined reported value of $219.93K across 358.87K shares. That is -2.6% by share count (-8.38K shares) versus the previous quarter, while reported value moved +19.3%. Ownership is concentrated: the five largest holders account for 72.3% of reported value and the top ten for 98.6%.
Compared with the prior quarter, 3 opened new positions, 5 added to existing stakes, 3 trimmed, 6 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of MATINAS BIOPHARMA HLDGS INC (MTNB) include HIGHBRIDGE CAPITAL MANAGEMENT LLC, Arkadios Wealth Advisors, Alliance Wealth Management Group, ranked by reported 13F value among the 89 institutional holders on this page.
MTNB is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 11 | 7.38K | $18.83K | -93.8% |
| Q2 2026 | 25 | 358.87K | $219.93K | -2.6% |
| Q1 2026 | 28 | 354.36K | $177.27K | -3.1% |
| Q4 2025 | 28 | 396.11K | $233.11K | -7.6% |
| Q3 2025 | 28 | 330.11K | $617.70K | +2.3% |
| Q2 2025 | 24 | 276.39K | $254.14K | +1.2% |
| Q1 2025 | 25 | 320.15K | $166.48K | -19.1% |
| Q4 2024 | 21 | 369.47K | $194.08K | -23.8% |
Over the 8 quarters shown, institutional share counts decreased 98% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q4 2024 (-23.8%).
Top Institutional Holders (Q3 2026) — 11 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 2.85K | $7.27K | 0.00% | Reduce | |
| 2.67K | $6.82K | 0.00% | Reduce | |
| 1.15K | $2.94K | 0.00% | Reduce | |
| 387 | $987 | 0.00% | New | |
| 204 | $520 | 0.00% | New | |
| 89 | $227 | 0.00% | Reduce | |
| 13 | $33 | 0.00% | Reduce | |
| 8 | $20 | 0.00% | Reduce | |
| 2 | $5 | 0.00% | Reduce | |
| 2 | $5 | 0.00% | Reduce | |
| 1 | $3 | 0.00% | New |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
Q1 2026 — 25 funds
Q4 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 65.73K | $38.52K | 0.00% | New | |
| 59.73K | $35.00K | 0.00% | Hold | |
| 55.97K | $32.80K | 0.00% | Hold | |
| 49.65K | $29.09K | 0.00% | Hold | |
| 32.48K | $20.14K | 0.01% | Hold | |
| 28.97K | $16.98K | 0.00% | Add | |
| 21.11K | $12.37K | 0.00% | New | |
| 16.91K | $9.91K | 0.00% | New | |
| 15.90K | $9.32K | 0.00% | New | |
| 15.57K | $9.00K | 0.00% | New | |
| 15.32K | $8.98K | 0.00% | Hold | |
| 12.72K | $7.45K | 0.00% | Reduce | |
| 2.86K | $1.68K | 0.00% | Add | |
| 991 | $581 | 0.00% | Add | |
| 607 | $356 | 0.00% | Add | |
| 561 | $328 | 0.00% | Hold | |
| 422 | $247 | 0.00% | Hold | |
| 200 | $117 | 0.00% | Hold | |
| 102 | $60 | 0.00% | Hold | |
| 61 | $36 | 0.00% | Hold | |
| 60 | $35 | 0.00% | Hold | |
| 60 | $35 | 0.00% | Hold | |
| 50 | $28 | 0.00% | Reduce | |
| 40 | $24 | 0.00% | Hold | |
| 14 | $8 | 0.00% | Hold |
Q3 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 59.73K | $112.88K | 0.00% | Hold | |
| 55.97K | $105.81K | 0.00% | Add | |
| 49.65K | $93.84K | 0.00% | Hold | |
| 36.62K | $69.21K | 0.01% | Add | |
| 32.48K | $55.54K | 0.03% | Hold | |
| 28.27K | $53.43K | 0.00% | Add | |
| 22.59K | $42.70K | 0.00% | New | |
| 15.32K | $28.96K | 0.00% | Hold | |
| 12.56K | $23.74K | 0.00% | New | |
| 10.78K | $20.00K | 0.00% | New | |
| 1.45K | $2.73K | 0.00% | Add | |
| 1.26K | $2.38K | 0.00% | New | |
| 979 | $1.85K | 0.00% | Hold | |
| 561 | $1.06K | 0.00% | Add | |
| 500 | $945 | 0.00% | New | |
| 422 | $798 | 0.00% | Add | |
| 210 | $394 | 0.00% | Hold | |
| 200 | $378 | 0.00% | Add | |
| 200 | $378 | 0.00% | Hold | |
| 102 | $193 | 0.00% | Hold | |
| 61 | $115 | 0.00% | Hold | |
| 60 | $114 | 0.00% | Hold | |
| 60 | $113 | 0.00% | Hold | |
| 40 | $76 | 0.00% | Hold | |
| 14 | $26 | 0.00% | Hold |
Q2 2025 — 24 funds
New Positions (Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 49.13K sh · $30.08K
- NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 20 sh · $12
- IFG Advisory, LLC 10 sh · $6
Fully Exited (vs previous quarter)
- XTX Topco Ltd sold 20.71K sh · $10.35K
- STATE STREET CORP sold 15.32K sh · $7.66K
- UBS Group AG sold 184 sh · $92
- Steward Partners Investment Advisory, LLC sold 61 sh · $31
- Fidelity Management & Research (FMR) sold 7 sh · $4
- MAI Capital Management sold 2 sh · $1
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | 2.85K | 50.26K | 49.65K | 49.65K | 49.65K | 49.65K | 49.65K | 49.65K | 49.65K | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.67K | 40.11K | 40.11K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 1.15K | 17.32K | 18.28K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Jacobi Capital Management LLC | 387 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| UBS Group AG | 204 | — | 184 | 607 | 200 | 110 | 1.64K | 12.31K | 3.43K | — | 44.89K | — | — | 14.31K | — | 11.85K | — | — | — | — |
| Vanguard Global Advisers, LLC | 89 | 1.34K | 1.34K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Costello Asset Management, INC | 13 | 200 | 200 | 200 | 200 | 200 | 200 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Morgan Stanley | 8 | 344 | 344 | 561 | 561 | 144 | 144 | 144 | 520 | 46.00K | 47.51K | 27.50K | 30.00K | 30.00K | 37.24K | 38.97K | 19.89K | 39.87K | 52.97K | 71.47K |
| OSAIC HOLDINGS, INC. | 2 | 52 | 50 | 50 | 210 | 210 | 210 | 200 | 200 | 10.00K | 10.00K | 10.00K | 12.00K | — | — | — | — | — | — | — |
| VISION FINANCIAL MARKETS LLC | 2 | 40 | 40 | 40 | 40 | 40 | 40 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Fidelity Management & Research (FMR) | 1 | — | 7 | — | 5 | 2 | 1 | — | — | — | 5.00K | 3.50K | — | — | — | — | — | — | 7.40K | — |
| Vanguard Group | — | — | — | 59.73K | 59.73K | 59.73K | 59.73K | 106.49K | 186.36K | 9.32M | 9.32M | 9.32M | 8.75M | 8.72M | 8.76M | 8.61M | 8.43M | 8.41M | 7.88M | 7.93M |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | — | — | — | — | — | — | — | — | 128.96K | 10.64M | — | — | — | — | — | — | — | — | — | — |
| Sargent Investment Group, LLC | — | 12.72K | 12.72K | 12.72K | 36.62K | 35.62K | 41.80K | 64.20K | 80.24K | 3.49M | 3.61M | 3.82M | 3.92M | — | — | — | — | — | — | — |
| Geode Capital Management | — | 49.13K | 65.17K | 55.97K | 55.97K | 55.49K | 46.74K | 43.47K | 46.73K | 2.29M | 2.14M | 1.58M | 1.96M | 1.96M | 1.80M | 1.80M | 1.69M | 1.55M | 1.63M | 1.59M |
| Arkadios Wealth Advisors | — | — | — | — | — | — | — | — | — | — | 1.62M | 1.62M | 1.40M | — | — | — | — | — | — | — |
| Northern Trust Corp | — | — | — | — | 22.59K | — | — | — | — | 430.31K | 430.65K | 362.28K | 362.28K | 362.28K | 363.46K | 346.58K | 346.58K | 318.32K | 318.32K | 330.82K |
| NEVILLE RODIE & SHAW INC | — | — | — | — | — | — | — | — | — | 1.16M | 1.16M | 1.16M | 1.16M | — | — | — | — | — | — | — |
| Alliance Wealth Management Group | — | — | — | — | — | — | — | — | — | 1.89M | — | — | — | — | — | — | — | — | — | — |
| Towercrest Capital Management | — | — | — | — | — | — | — | — | — | 1.89M | — | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold MTNB?
As of 2026-Q2, 25 institutional funds reported holding MTNB (MATINAS BIOPHARMA HLDGS INC) in SEC 13F filings, with a combined reported value of $219.93K.
How many shares of MTNB do institutions own?
13F filers reported 358.87K shares of MTNB, worth $219.93K in aggregate at the end of 2026-Q2.
Is institutional ownership of MTNB rising or falling?
Share counts moved -2.6% versus the prior quarter — distribution.
Who are the top institutional holders of MTNB?
The largest 13F holders are HIGHBRIDGE CAPITAL MANAGEMENT LLC, Arkadios Wealth Advisors, Alliance Wealth Management Group, Towercrest Capital Management, NEVILLE RODIE & SHAW INC; the top 25 are ranked at the top of this page.
Who are the major shareholders of MATINAS BIOPHARMA HLDGS INC?
The major shareholders of MATINAS BIOPHARMA HLDGS INC (MTNB) by reported 13F value are HIGHBRIDGE CAPITAL MANAGEMENT LLC, Arkadios Wealth Advisors, Alliance Wealth Management Group, Towercrest Capital Management, NEVILLE RODIE & SHAW INC, among 89 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.